<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Chacko, Matthews</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Transcatheter Aortic Valve Replacement Effective for Severe Aortic Stenosis</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">This article presented data from an international multicenter study to evaluate a cardiac valve designed for placement without the need for a median sternotomy. Transcatheter aortic valve replacement (TAVR) performed as well as surgical aortic valve replacement (SAVR), and improved survival at 1 and 2 years compared with medical management in patients with severe aortic stenosis (AS). The Placement of Aortic Transcatheter Valve trial [PARTNER; Leon MB et al. N Engl J Med 2010] was designed to investigate the safety and effectiveness of TAVR in patients with severe AS.</style></abstract><number><style face="normal" font="default" size="100%">14</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>